FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB), a leading cell analysis ...
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of ...
FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.
KANSAS CITY, Kan.--(BUSINESS WIRE)--KCAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a leading ...
FREMONT, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Clinical flow cytometry laboratories based in Europe can now go beyond 24 colors – easily and affordably. Cytek Biosciences Inc., a leading provider ...
Flow cytometry is an invaluable method for biomedical research. Since its development over 50 years ago, technology for flow cytometry has progressed rapidly, allowing for the detection of more and ...
This article and associated images are based on a poster originally authored by Sharon Sanderson, Michael Blundell, and Tracey Long and presented at ELRIG Drug Discovery 2025 in affiliation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results